InvestorsHub Logo
Followers 3
Posts 1199
Boards Moderated 0
Alias Born 01/19/2010

Re: var734 post# 5126

Thursday, 06/17/2010 2:05:29 PM

Thursday, June 17, 2010 2:05:29 PM

Post# of 19507
I think COV and POSC are saying it together in their releases.

From Ricks post http://investorshub.advfn.com/boards/read_msg.aspx?message_id=51406662

Covidien News Conference: The CEO Stated this...
A. He essentially just said that they got rid of the radiopharmaceuticals branch because that wasn't their specialty. He continued by saying it makes much more sense to work and partner with companies that instead specialize in radiopharmaceuticals. (THIS WAS THE CLEAREST SIGNAL SO FAR FROM COVIDIEN THAT SOMETHING IS BREWING).
B. They are doing a lot of research on additional mergers and acquistions and expect more to come.
C. They are focussing on companies that are going to have significant long term growth.

from yahoo message board concerning todays COV presentation



From today's POSC new release http://investorshub.advfn.com/boards/read_msg.aspx?message_id=51411488

-- Positron has an agreement with an industry leading partner for the development and distribution of cardiac radiopharmaceuticals. This partnership represents thousands of potential customers throughout the US and world. Each distributed Nuclear Pharm-Assist(R) system represents approximately $250,000 in annual sales. This pending rollout will be the beginning of Positron being a leader in radiopharmaceutical distribution.